38 employees
Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.
2020
$50M
from 2 investors over 2 rounds
Ascidian Therapeutics raised $50M on October 12, 2022
Investors: ATP (Apple Tree Partners)
Ascidian Therapeutics raised undisclosed on January 1, 2021